To enhance tumor targeting, transferrin was modified on the surface of MeTTh (MeTTh NPs-Tf) and combined with FUS to open the BBB, enabling MeTTh NPs-Tf to successfully target GBM, which exhibited significant tumor growth inhibition as well as enabling deep brain imaging [122]. Here, TF is linked to glioblastoma.